Galaxeye Space Solutions Limited Private Limited Unlisted Shares

About Company

1. Introduction

GalaxEye Space Solutions Private Limited is an Indian spacetech company building multi-sensor Earth-observation satellites. It was incubated at IIT Madras and founded in 2021 by a team of five students/alumni who had previously worked together as part of Team Avi. The company is based in Bengaluru, with its registered office in Chennai.

Its core business centers on the flagship "Mission Drishti" satellite program, which combines SAR (Synthetic Aperture Radar) and multispectral imaging on a single platform — enabling all-weather, day-and-night Earth observation. GalaxEye's business model revolves around selling analysis-ready satellite imagery and related geospatial datasets to enterprises and governments, primarily for defence, infrastructure monitoring, agriculture, and similar use cases.

2. What it does

GalaxEye's core product is "OptoSAR" — the world's first commercial satellite system fusing Synthetic Aperture Radar (SAR) with a 7-band multispectral imager (MSI) on a single platform. This enables all-weather, day-and-night imaging and delivers aligned, analysis-ready data without needing to merge imagery from separate sensors, cutting down on dataset-labeling and AI-model-development effort while yielding roughly three times more information than a standalone sensor.

Its flagship program, Mission Drishti, aims for a 10-satellite constellation by 2029. The first satellite (~190 kg) uses electric propulsion, launches via SpaceX, and delivers 1–1.5m resolution imagery with a 7–10 day revisit time. Gen-2 satellites (~300 kg) will offer 0.5m resolution. Key use cases span defence, infrastructure monitoring, and agriculture.

3. Business Model & Revenue

• Model: Data-and-services model — commercializes Earth-observation imagery and derived datasets to government and enterprise customers rather than selling consumer products. Described variously as B2B2C and B2G across public profiles.

• Revenue streams: Satellite imagery sales, dataset subscriptions, custom analytics, and long-term contracts for recurring data access or mission-specific outputs.

• Positioning: Offers stable, standardized imagery that developers, enterprises, and resellers can build on.

• Key sectors served: Disaster management, marine, insurance, energy & utility, mining, and defense.

• Geographic focus: Commercialization targeted across the U.S., Europe, and Africa.

• Government partnership: Agreement with government-owned NewSpace India Ltd (NSIL) to resell satellite imagery.

• Revenue (FY25): ₹2.02 Cr (~$240K) for the year ending March 31, 2025, with a reported 1-year revenue CAGR of 7676% — off a very small base, typical for a pre-launch deep-tech startup.

4. Founders and Promoters

GalaxEye was founded in 2021 by a team from IIT Madras. As Per the company's own website, the founding team includes:

• Suyash Singh — CEO & Co-Founder

• Denil Chawda — CTO & Co-Founder

• Pranit Mehta — VP, Sales Ops & Co-Founder

• Kishan Thakkar — VP, Engineering & Co-Founder

• Rakshit Bhatt — VP, Product & Co-Founder

5. Recent news

i) In February 2026, GalaxEye signed a channel partnership with NewSpace India Limited (NSIL), which will market/resell the company’s OptoSAR satellite data. This was described as the first such partnership between NSIL and an Indian private satellite-data company.thehindubusinessline+1

ii) In March 2026, the company closed a funding transaction and received INR 442 million in the final tranche, according to a market news report.

iii) In early March 2026, the company said it was moving toward 300-kg second-generation OptoSAR satellites with about 0.5-metre resolution, and was preparing a new Bengaluru facility.

iv) On 3 May 2026, GalaxEye launched Mission Drishti aboard a SpaceX Falcon 9 rocket, and media reports described it as the world’s first OptoSAR satellite.

v) The company’s own updates also mention that Mission Drishti was scheduled for a Q1 2026 launch and that earlier milestones included a successful ISRO POEM demo and SAR-related trials.